Source: Annual Congress 2013 –Treatment of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Mahashur, D. Talwar, R. Guleria, M. Kotnis (Mumbai, Noida, Delhi, India). Outcomes with omalizumab in Indian patients with allergic (IgE-mediated) asthma: Results at 16 and 28 weeks. Eur Respir J 2013; 42: Suppl. 57, 907

Member's Comments

No comment yet.

Related content which might interest you: Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study Source: International Congress 2016 – Asthma points to ponder Year: 2016 Health related quality of life in asthmatic subjects after 3 months treatment with inhaled corticosteroids Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Bronchial thermoplasty in patients with very severe asthma: Safety and clinical outcomes Source: International Congress 2016 – Airway stenting and ablation Year: 2016 Fluticasone propionate/formoterol therapy for asthmatic patients: Results of a non-interventional study Source: International Congress 2016 – Asthma management Year: 2016 P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients Source: International Congress 2016 – Asthma management Year: 2016 Efficacy and safety of fevipiprant (QAW039) in patients with atopic asthma uncontrolled on low-dose ICS therapy Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Asthma control, symptoms and exacerbations across treatment levels in patients with asthma Source: Annual Congress 2013 –Management of respiratory diseases in primary care Year: 2013 SQ HDM SLIT-tablet is effective in patients not well-controlled in GINA treatment steps 2-4 Source: International Congress 2016 – Asthma management Year: 2016 Reslizumab (RES) in asthma patients (pts) with severe eosinophilic asthma stratified by GINA asthma steps 4 and 5: Analysis of two phase 3, placebo (PBO)-controlled trials Source: International Congress 2016 – Asthma management Year: 2016 Real life experience of omalizumab on selected children with severe allergic asthma Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016 Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Long-term (5 year) safety of bronchial thermoplasty in patients with moderate to severe asthma: Asthma Intervention Research (AIR) Trial Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Total and free IgE in evolution of severe asthma after omalizumab treatment Source: International Congress 2016 – Asthma management Year: 2016 Quality of life and asthma control in elderly asthmatics: A seven year follow-up – Results from the PRAXIS study Source: International Congress 2016 – Asthma management in primary care Year: 2016 Patients with allergic and eosinophilic asthma in the German severe asthma registry Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Adherence to the treatment of patients with bronchial asthma Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 The control of asthma in real life: Baseline evaluation of a long-term study Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016